Of note, serum and hepatic levels of PKM2 are increased in both metabolic syndrome and NAFLD, but they decreased after Roux-en-Y gastric bypass surgery, one of the most commonly performed weight-loss procedures, implying that systematic PKM2 expression may represent the disease stage of NAFLD [43]. Here, PKM is linked to metabolic dysfunction-associated steatotic liver disease.